OUR PIPELINE

 Oncorus' Pipeline

At Oncorus, we are committed to bringing innovative therapies to patients in need. If you have an interest in our platform and believe we can work together to achieve this vision, please reach out at partnering@oncorus.com.

 ONCR-1

  ONCR-1

  • In development for glioblastoma multiforme
  • miR-attenutated virus
  • 2 payloads to enhance immune cell activation and trafficking and to facilitate viral spread by degrading fibrotic tumor matrix
  • Delivered by intratumoral injection
 ONCR-2

  ONCR-2  

  • Multi-solid tumor indications
  • Multi miR-attenuated virus 
  • Capacity to include up to 8 payloads 
  • Delivered by intratumoral injection

SYSTEMIC DELIVERY

Oncorus is developing a disruptive suite of technologies to overcome the 3 main challenges of systemic application of oncolytic viruses for cancer therapy

  1. Stealth-ing of virus to prevent immune detection before reaching tumor target

  2. Tumor specific targeting to enable efficacy at reduced dose

  3. Enabling robust and cost-effective manufacturing